Purchases and Sales Made in Q4 2024 in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS) during Q4 2024. The information is specifically focused on institutions that hold shares of Apellis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-16.9K- 99.71% |
$442K - $599K
|
50
$1.38K
|
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-19.9K- 5.25% |
$520K - $704K
|
359K
$9.87M
|
|
|
Feb 07, 2025
Q4 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-20.7K- 72.59% |
$543K - $735K
|
7.84K
$216K
|
|
|
Feb 06, 2025
Q4 2024
|
Assetmark, Inc
|
SELL
|
- |
-46K- 99.93% |
$1.21M - $1.63M
|
31
$853
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-85.7K- 43.26% |
$2.24M - $3.04M
|
112K
$3.09M
|
|
|
Feb 11, 2025
Q4 2024
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-89.7K- 31.17% |
$2.35M - $3.18M
|
198K
$5.45M
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-96.3K- 37.64% |
$2.52M - $3.41M
|
160K
$4.39M
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-100K- 26.97% |
$2.63M - $3.56M
|
272K
$7.48M
|
|
|
Feb 13, 2025
Q4 2024
|
Capital Fund Management S.A.
Paris, I0 |
SELL
|
- |
-122K- 50.08% |
$3.19M - $4.31M
|
121K
$3.34M
|
|
|
Feb 14, 2025
Q4 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-126K- 2.86% |
$3.29M - $4.45M
|
4.27M
$118M
|
|
|
Feb 12, 2025
Q4 2024
|
Envestnet Asset Management Inc
|
SELL
|
- |
-128K- 82.04% |
$3.34M - $4.52M
|
28K
$769K
|
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-134K- 95.97% |
$3.5M - $4.74M
|
5.62K
$155K
|
|
|
Feb 06, 2025
Q4 2024
|
Candriam S.C.A.
|
SELL
|
- |
-140K- 20.65% |
$3.68M - $4.97M
|
540K
$14.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-146K- 84.74% |
$3.81M - $5.16M
|
26.2K
$721K
|
|
|
Feb 13, 2025
Q4 2024
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-172K- 46.78% |
$4.5M - $6.09M
|
196K
$5.38M
|
|
|
Feb 11, 2025
Q4 2024
|
Td Asset Management Inc
|
SELL
|
- |
-200K- 83.76% |
$5.22M - $7.07M
|
38.7K
$1.06M
|
|
|
Jan 31, 2025
Q4 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-328K- 87.03% |
$8.58M - $11.6M
|
48.8K
$1.34M
|
|
|
Feb 14, 2025
Q4 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-469K- 57.54% |
$12.3M - $16.6M
|
346K
$9.52M
|
|
|
Feb 14, 2025
Q4 2024
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-1.03M- 32.84% |
$26.9M - $36.4M
|
2.1M
$57.8M
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-2.11M- 98.6% |
$55.4M - $74.9M
|
30K
$825K
|
|
|
Feb 14, 2025
Q4 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-2.94M- 98.4% |
$76.9M - $104M
|
47.7K
$1.31M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3.47M- 89.41% |
$90.9M - $123M
|
412K
$11.3M
|
|
|
Feb 12, 2025
Q4 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-3.77M- 24.19% |
$98.6M - $133M
|
11.8M
$325M
|